COVID mutant: Govt says focus on enhanced genomic surveillance; Taskforce suggests no change in treatment protocol

The genomic surveillance consortium, INSACOG, has been formed under the leadership of the National Centre for Disease Control (NCDC), New Delhi. Further, more than 50 samples of UK returnees are currently under sequencing at the designated laboratories.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37PLHIE
via IFTTT